Breaking News Instant updates and real-time market news.

AFLYY

Air France-KLM

$0.00 /

+ (+0.00%)

17:14
04/24/20
04/24
17:14
04/24/20
17:14

Air France-KLM wins nearly EUR10B in French, Dutch loans, FT reports

Air France-KLM has been awarded nearly EUR10B in state assistance from the French and Dutch governments as the company aims to avoid a liquidity crunch due to the economic impacts of COVID-19 on the airline industry, the Financial Times' David Keohane and Mehreen Khan report. The French government confirmed that it had agreed to a EUR7B loan package for the company while the Dutch government said it was still in negotiations but pledged EUR2B-EUR4B, the authors note. "Air France's planes are grounded, so we need to support Air France," said Bruno Le Maire, French finance minister, adding that the loans would come with conditions, including that the company "must become the most environmentally friendly company on the planet." Reference Link

AFLYY Air France-KLM
$0.00 /

+ (+0.00%)

04/24/20 Barclays
Air France-KLM price target lowered to EUR 4.20 from EUR 10.30 at Barclays
04/24/20 Societe Generale
Air France-KLM cut to Sell on slow recovery expectations at Societe Generale
04/24/20 Societe Generale
Air France-KLM downgraded to Sell from Hold at Societe Generale
04/23/20 Morgan Stanley
Air France-KLM downgraded to Underweight from Equal Weight at Morgan Stanley

TODAY'S FREE FLY STORIES

On The Fly
Regenxbio slips as Novartis' Zolgensma expansion hits FDA roadblock » 12:10
09/23/20
09/23
12:10
09/23/20
12:10
NVS

Novartis

$88.10 /

-0.77 (-0.87%)

, RGNX

Regenxbio

$28.28 /

-0.59 (-2.04%)

, IONS

Ionis Pharmaceuticals

$50.11 /

-0.63 (-1.24%)

, BIIB

Biogen

$275.85 /

+3.07 (+1.13%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, PTCT

PTC Therapeutics

$46.18 /

+0.06 (+0.13%)

Shares of Regenxbio…

ShowHide Related Items >><<
NVS Novartis
$88.10 /

-0.77 (-0.87%)

RGNX Regenxbio
$28.28 /

-0.59 (-2.04%)

IONS Ionis Pharmaceuticals
$50.11 /

-0.63 (-1.24%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$46.18 /

+0.06 (+0.13%)

NVS Novartis
$88.10 /

-0.77 (-0.87%)

09:34 Today BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
05:22 Today Oddo BHF
Novartis downgraded to Neutral from Buy at Oddo BHF
09/10/20 UBS
Novartis upgraded to Buy from Neutral at UBS
RGNX Regenxbio
$28.28 /

-0.59 (-2.04%)

09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
08/06/20 Roth Capital
Investors should buy 'highly undervalued' Clearside, says Roth Capital
06/25/20 BofA
Regenxbio reinstated with a Buy at BofA
05/12/20 RBC Capital
Regenxbio initiated with a Sector Perform at RBC Capital
IONS Ionis Pharmaceuticals
$50.11 /

-0.63 (-1.24%)

09:34 Today BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/22/20 Cantor Fitzgerald
Ionis Pharmaceuticals price target raised to $59 from $56 at Cantor Fitzgerald
09/14/20 JPMorgan
Ionis Pharmaceuticals resumed with a Neutral at JPMorgan
BIIB Biogen
$275.85 /

+3.07 (+1.13%)

09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/18/20 RBC Capital
Biogen price target lowered to $277 from $284 at RBC Capital
09/17/20 Morgan Stanley
Court ruling eliminates hurdle for Tecfidera generics, says Morgan Stanley
09/16/20 Raymond James
Mylan exclusivity on Tecfidera generic abruptly ending, says Raymond James
RHHBY Roche
$0.00 /

+ (+0.00%)

09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
07:45 Today BMO Capital
Blueprint Medicines price target raised to $113 from $105 at BMO Capital
05:12 Today Oddo BHF
Roche downgraded to Reduce from Buy at Oddo BHF
09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
PTCT PTC Therapeutics
$46.18 /

+0.06 (+0.13%)

09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
08/24/20 Raymond James
PTC Therapeutics initiated with an Outperform at Raymond James
08/11/20 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $85 at Cantor Fitzgerald
07/20/20 Credit Suisse
Credit Suisse downgrades PTC Therapeutics after risdiplam royalty deal
NVS Novartis
$88.10 /

-0.77 (-0.87%)

RGNX Regenxbio
$28.28 /

-0.59 (-2.04%)

IONS Ionis Pharmaceuticals
$50.11 /

-0.63 (-1.24%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$46.18 /

+0.06 (+0.13%)

NVS Novartis
$88.10 /

-0.77 (-0.87%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$46.18 /

+0.06 (+0.13%)

NVS Novartis
$88.10 /

-0.77 (-0.87%)

IONS Ionis Pharmaceuticals
$50.11 /

-0.63 (-1.24%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$46.18 /

+0.06 (+0.13%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

Hot Stocks
Spotify testing new Polls feature for podcasts » 12:09
09/23/20
09/23
12:09
09/23/20
12:09
SPOT

Spotify

$237.96 /

-3.54 (-1.47%)

Spotify said it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
$237.96 /

-3.54 (-1.47%)

SPOT Spotify
$237.96 /

-3.54 (-1.47%)

09/14/20 KeyBanc
Spotify initiated with a Sector Weight at KeyBanc
09/14/20 KeyBanc
Spotify initiated with a Sector Weight at KeyBanc
09/10/20
Fly Intel: Top five analyst upgrades
09/09/20 Credit Suisse
Credit Suisse raises Spotify subscriber estimates, upgrades to Outperform
SPOT Spotify
$237.96 /

-3.54 (-1.47%)

SPOT Spotify
$237.96 /

-3.54 (-1.47%)

SPOT Spotify
$237.96 /

-3.54 (-1.47%)

SPOT Spotify
$237.96 /

-3.54 (-1.47%)

Recommendations
Taylor Wimpey price target lowered to 120 GBp from 165 GBp at Morgan Stanley » 12:06
09/23/20
09/23
12:06
09/23/20
12:06
TWODF

Taylor Wimpey

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWODF Taylor Wimpey
$0.00 /

+ (+0.00%)

09/16/20 BofA
Taylor Wimpey downgraded to Underperform from Neutral at BofA
09/11/20 JPMorgan
Taylor Wimpey price target lowered to 130 GBp from 140 GBp at JPMorgan
08/26/20 JPMorgan
Taylor Wimpey price target lowered to 140 GBp from 150 GBp at JPMorgan
07/30/20 Canaccord
Taylor Wimpey upgraded to Buy from Hold at Canaccord
Recommendations
Wizz Air price target raised to 4,500 GBp from 3,800 GBp at Morgan Stanley » 12:06
09/23/20
09/23
12:06
09/23/20
12:06
WZZAF

Wizz Air

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WZZAF Wizz Air
$0.00 /

+ (+0.00%)

07/31/20 Berenberg
Wizz Air price target raised to 4,200 GBp from 4,000 GBp at Berenberg
07/30/20 JPMorgan
Wizz Air price target raised to 4,200 GBp from 4,150 GBp at JPMorgan
07/30/20 UBS
Wizz Air price target raised to 3,385 GBp from 3,255 GBp at UBS
07/24/20 Credit Suisse
Wizz Air initiated with an Outperform at Credit Suisse
Syndicate
Corsair Gaming opens at $15.12, IPO priced at $17 per share  12:06
09/23/20
09/23
12:06
09/23/20
12:06
CRSR

Corsair Gaming

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 23
    Sep
Recommendations
Ryanair price target raised to EUR 16 from EUR 15 at Morgan Stanley » 12:05
09/23/20
09/23
12:05
09/23/20
12:05
RYAAY

Ryanair

$80.36 /

+0.74 (+0.93%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RYAAY Ryanair
$80.36 /

+0.74 (+0.93%)

RYAAY Ryanair
$80.36 /

+0.74 (+0.93%)

09/22/20 UBS
Ryanair price target raised to EUR 14.85 from EUR 13.50 at UBS
09/22/20 Peel Hunt
Ryanair initiated with a Sell at Peel Hunt
09/14/20 Liberum
Ryanair downgraded to Hold from Buy at Liberum
09/08/20 AlphaValue
Ryanair upgraded to Add from Sell at AlphaValue
RYAAY Ryanair
$80.36 /

+0.74 (+0.93%)

Recommendations
Knorr-Bremse price target raised to EUR 112 from EUR 110 at Morgan Stanley » 12:05
09/23/20
09/23
12:05
09/23/20
12:05
KNRRY

Knorr-Bremse

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KNRRY Knorr-Bremse
$0.00 /

+ (+0.00%)

09/17/20 JPMorgan
Knorr-Bremse price target raised to EUR 94 from EUR 93 at JPMorgan
09/14/20 Berenberg
Knorr-Bremse price target raised to EUR 99 from EUR 89 at Berenberg
09/11/20 JPMorgan
Knorr-Bremse Q2 results in-line with pre-announcement, says JPMorgan
09/03/20 Societe Generale
Knorr-Bremse initiated with a Buy at Societe Generale
KNRRY Knorr-Bremse
$0.00 /

+ (+0.00%)

Options
MGM Resorts call volume above normal and directionally bullish » 12:05
09/23/20
09/23
12:05
09/23/20
12:05
MGM

MGM Resorts

$21.90 /

+0.27 (+1.25%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGM MGM Resorts
$21.90 /

+0.27 (+1.25%)

MGM MGM Resorts
$21.90 /

+0.27 (+1.25%)

09/16/20
Fly Intel: Top five analyst downgrades
09/16/20 Roth Capital
MGM Resorts downgraded to Neutral from Buy at Roth Capital
09/14/20
Fly Intel: Top five analyst downgrades
09/14/20 Goldman Sachs
MGM Resorts downgraded to Sell from Neutral at Goldman Sachs
MGM MGM Resorts
$21.90 /

+0.27 (+1.25%)

MGM MGM Resorts
$21.90 /

+0.27 (+1.25%)

MGM MGM Resorts
$21.90 /

+0.27 (+1.25%)

MGM MGM Resorts
$21.90 /

+0.27 (+1.25%)

Recommendations
Kingfisher price target raised to 340 GBp from 320 GBp at Morgan Stanley » 12:04
09/23/20
09/23
12:04
09/23/20
12:04
KGFHY

Kingfisher

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KGFHY Kingfisher
$0.00 /

+ (+0.00%)

09/04/20 Exane BNP Paribas
Kingfisher upgraded to Outperform from Neutral at Exane BNP Paribas
08/10/20 Morgan Stanley
Kingfisher price target raised to 320 GBp from 290 GBp at Morgan Stanley
07/27/20 RBC Capital
Kingfisher price target raised to 325 GBp from 275 GBp at RBC Capital
07/27/20 Credit Suisse
Kingfisher upgraded to Outperform from Neutral at Credit Suisse
Recommendations
G4S price target raised to 170 GBp from 155 GBp at Morgan Stanley » 12:03
09/23/20
09/23
12:03
09/23/20
12:03
GFSZY

G4S

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GFSZY G4S
$0.00 /

+ (+0.00%)

GFSZY G4S
$0.00 /

+ (+0.00%)

09/15/20 RBC Capital
G4S price target raised to 215 GBp from 180 GBp at RBC Capital
08/27/20 Morgan Stanley
G4S price target raised to 155 GBp from 150 GBp at Morgan Stanley
08/06/20 RBC Capital
G4S price target raised to 180 GBp from 160 GBp at RBC Capital
07/24/20 JPMorgan
G4S price target raised to 160 GBp from 125 GBp at JPMorgan
Hot Stocks
Steelcase falls -13.5% » 12:00
09/23/20
09/23
12:00
09/23/20
12:00
SCS

Steelcase

$9.82 /

-1.545 (-13.60%)

Steelcase is down -13.5%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCS Steelcase
$9.82 /

-1.545 (-13.60%)

SCS Steelcase
$9.82 /

-1.545 (-13.60%)

09/15/20 Sidoti
Steelcase upgraded to Buy from Neutral at Sidoti
08/24/20 Benchmark
Steelcase downgraded to Hold on lack of near-term catalysts at Benchmark
08/24/20 Benchmark
Steelcase downgraded to Hold from Buy at Benchmark
05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
SCS Steelcase
$9.82 /

-1.545 (-13.60%)

SCS Steelcase
$9.82 /

-1.545 (-13.60%)

SCS Steelcase
$9.82 /

-1.545 (-13.60%)

Hot Stocks
Lithium Americas falls -18.1% » 12:00
09/23/20
09/23
12:00
09/23/20
12:00
LAC

Lithium Americas

$7.40 /

-1.62 (-17.96%)

Lithium Americas is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LAC Lithium Americas
$7.40 /

-1.62 (-17.96%)

LAC Lithium Americas
$7.40 /

-1.62 (-17.96%)

09:35 Today BMO Capital
BMO thinks Tesla project rights not related to Lithium Americas
06/25/20 BMO Capital
Lithium Americas price target raised to C$5 from C$4.40 at BMO Capital
LAC Lithium Americas
$7.40 /

-1.62 (-17.96%)

LAC Lithium Americas
$7.40 /

-1.62 (-17.96%)

LAC Lithium Americas
$7.40 /

-1.62 (-17.96%)

Hot Stocks
Aurora Cannabis falls -24.1% » 12:00
09/23/20
09/23
12:00
09/23/20
12:00
ACB

Aurora Cannabis

$5.56 /

-1.76 (-24.04%)

Aurora Cannabis is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$5.56 /

-1.76 (-24.04%)

ACB Aurora Cannabis
$5.56 /

-1.76 (-24.04%)

07:59 Today MKM Partners
Aurora Cannabis price target lowered to C$9 from C$18 at MKM Partners
05:55 Today Piper Sandler
Aurora Cannabis price target lowered to $8 from $10 at Piper Sandler
09/22/20 Canaccord
Aurora Cannabis price target lowered to C$10 from C$21 at Canaccord
09/21/20 Jefferies
Jefferies upgrades Aurora Cannabis to Hold, cuts price target to C$8.70
ACB Aurora Cannabis
$5.56 /

-1.76 (-24.04%)

ACB Aurora Cannabis
$5.56 /

-1.76 (-24.04%)

ACB Aurora Cannabis
$5.56 /

-1.76 (-24.04%)

ACB Aurora Cannabis
$5.56 /

-1.76 (-24.04%)

Hot Stocks
Hilltop Holdings rises 13.5% » 12:00
09/23/20
09/23
12:00
09/23/20
12:00
HTH

Hilltop Holdings

$20.65 /

+2.39 (+13.09%)

Hilltop Holdings is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HTH Hilltop Holdings
$20.65 /

+2.39 (+13.09%)

HTH Hilltop Holdings
$20.65 /

+2.39 (+13.09%)

08/14/20 Stephens
Hilltop Holdings upgraded to Overweight from Equal Weight at Stephens
08/14/20 Stephens
Hilltop Holdings upgraded to Overweight from Equal Weight at Stephens
HTH Hilltop Holdings
$20.65 /

+2.39 (+13.09%)

Hot Stocks
Amwell rises 16.6% » 12:00
09/23/20
09/23
12:00
09/23/20
12:00
AMWL

Amwell

$28.81 /

+4.28 (+17.45%)

Amwell is up 16.6%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMWL Amwell
$28.81 /

+4.28 (+17.45%)

  • 17
    Sep
AMWL Amwell
$28.81 /

+4.28 (+17.45%)

AMWL Amwell
$28.81 /

+4.28 (+17.45%)

Hot Stocks
JinkoSolar rises 19.1% » 12:00
09/23/20
09/23
12:00
09/23/20
12:00
JKS

JinkoSolar

$32.80 /

+5.11 (+18.45%)

JinkoSolar is up 19.1%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JKS JinkoSolar
$32.80 /

+5.11 (+18.45%)

JKS JinkoSolar
$32.80 /

+5.11 (+18.45%)

09/21/20 Roth Capital
JinkoSolar price target raised to $29 from $22 at Roth Capital
07/20/20 Roth Capital
Roth boosts Daqo target to $120 after polysilicon facility explosion reports
06/15/20 GLJ Research
Solar space earnings likely cut through remainder of 2020, says GLJ Research
04/08/20 GLJ Research
JinkoSolar price target lowered to $6.88 from $7.97 at GLJ Research
JKS JinkoSolar
$32.80 /

+5.11 (+18.45%)

JKS JinkoSolar
$32.80 /

+5.11 (+18.45%)

JKS JinkoSolar
$32.80 /

+5.11 (+18.45%)

Recommendations
AkzoNobel price target raised to EUR 112 from EUR 105 at Morgan Stanley » 11:59
09/23/20
09/23
11:59
09/23/20
11:59
AKZOY

AkzoNobel

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKZOY AkzoNobel
$0.00 /

+ (+0.00%)

09/14/20 JPMorgan
AkzoNobel price target raised to EUR 90 from EUR 78 at JPMorgan
08/11/20 Barclays
AkzoNobel price target raised to EUR 96 from EUR 95 at Barclays
07/24/20 Berenberg
AkzoNobel price target raised to EUR 92 from EUR 70 at Berenberg
07/24/20 Berenberg
AkzoNobel price target raised to EUR 92 from EUR 70 at Berenberg
Conference/Events
Arvinas participates in a conference call with Cantor Fitzgerald » 11:59
09/23/20
09/23
11:59
09/23/20
11:59
ARVN

Arvinas

$25.42 /

-0.75 (-2.87%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARVN Arvinas
$25.42 /

-0.75 (-2.87%)

ARVN Arvinas
$25.42 /

-0.75 (-2.87%)

06/01/20 Citi
Arvinas upgraded to Buy from Neutral at Citi
05/29/20 Roth Capital
Roth Capital recommends buying Arvinas on ASCO dip
05/29/20 Piper Sandler
Arvinas should be bought on weakness after ASCO update, says Piper Sandler
05/15/20 Roth Capital
Roth Capital maintains positive outlook on Arvinas after ASCO abstract review
ARVN Arvinas
$25.42 /

-0.75 (-2.87%)

  • 07
    Nov
ARVN Arvinas
$25.42 /

-0.75 (-2.87%)

Syndicate
Corsair Gaming indicated to open at $15.50, IPO priced at $17  11:58
09/23/20
09/23
11:58
09/23/20
11:58
CRSR

Corsair Gaming

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 23
    Sep
Syndicate
GoodRx indicated to open at $45, IPO priced at $33  11:57
09/23/20
09/23
11:57
09/23/20
11:57
GDRX

GoodRx

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 23
    Sep
General news
Chair Powell hasn't added anything new » 11:55
09/23/20
09/23
11:55
09/23/20
11:55

Chair Powell hasn't…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Federal Reserve Bank of Boston president speaks about the economy » 11:55
09/23/20
09/23
11:55
09/23/20
11:55

Boston Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Laird Superfood opens at $33.55, IPO priced at $22 per share » 11:54
09/23/20
09/23
11:54
09/23/20
11:54
LSF

Laird Superfood

$0.00 /

+ (+0.00%)

Laird Superfood (LSF)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 23
    Sep
Hot Stocks
Clear Touch announces contract with Liberty AV solutions » 11:53
09/23/20
09/23
11:53
09/23/20
11:53
WCC

Wesco

$43.16 /

-0.06 (-0.14%)

Clear Touch announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WCC Wesco
$43.16 /

-0.06 (-0.14%)

WCC Wesco
$43.16 /

-0.06 (-0.14%)

08/18/20 Oppenheimer
Wesco price target raised to $65 from $55 at Oppenheimer
08/14/20 Raymond James
Wesco price target raised to $65 from $60 at Raymond James
07/17/20 Gordon Haskett
Leonard Green position in Wesco 'particularly interesting,' says Gordon Haskett
06/24/20 Baird
Wesco downgraded to Neutral from Outperform at Baird
WCC Wesco
$43.16 /

-0.06 (-0.14%)

Hot Stocks
Javelin Biotech announces 'organ-on-a-chip' collaboration with Pfizer » 11:53
09/23/20
09/23
11:53
09/23/20
11:53
PFE

Pfizer

$36.25 /

-0.01 (-0.03%)

Javelin Biotech, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$36.25 /

-0.01 (-0.03%)

PFE Pfizer
$36.25 /

-0.01 (-0.03%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Baird
uniQure weakness a buying opportunity, says Baird
09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
PFE Pfizer
$36.25 /

-0.01 (-0.03%)

PFE Pfizer
$36.25 /

-0.01 (-0.03%)

PFE Pfizer
$36.25 /

-0.01 (-0.03%)

PFE Pfizer
$36.25 /

-0.01 (-0.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.